Pregnancy and the Hair Growth Cycle: Anagen Induction Against Hair Growth Disruption Using Nourkrin with Marilex, a Proteoglycan Replacement Therapy

The document from 2016 examines postpartum effluvium, a condition causing hair loss after childbirth due to hormonal changes that disrupt the hair growth cycle. It highlights the role of proteoglycans in hair follicle health and how their levels drop, along with a rise in cortisol levels, during and after pregnancy. The paper presents Nourkrin® with Marilex®, a proteoglycan replacement therapy, as a potential treatment to induce the anagen phase and combat hair loss. A double-blind placebo-controlled trial mentioned in the document showed a 35.7% increase in hair count over 6 months with this therapy. The paper calls for more research into the biological mechanisms of postpartum effluvium to create targeted treatments for long-term hair preservation.